Table 4. Daily number of fixed dose tablet in the control arm (arm R10PO) during week 0–8 and for all arms during the continuation phase of treatment.
Weight | Intensive Phase (week 0–8) | Continuation Phase
(month 3–12) |
|
---|---|---|---|
RHZE fixed dose combination daily
(150/75/400/275 mg) 3 |
RH (150/75) 3 | RH (300/150) 3 | |
30–37 kg | 2 tabs | 2 tabs | |
38–54 kg | 3 tabs | 3 tabs | |
55–70 kg | 4 tabs | 2 tabs | |
≥ 71 kg | 5 tabs | 2 tabs |